MHLW Research Team Develops Universal Flu Vaccine
This article was originally published in PharmAsia News
Executive Summary
A research team at the Ministry of Health, Labor and Welfare announced Jan. 29 that it has developed a universal flu vaccine. Led by National Institute of Infectious Disease Chief Researcher Tetsuya Uchida, the team made the vaccine based on common protein found in three highly mutated flu virus types, H5N1, H1N1 and a Hong Kong type. The team confirmed efficacy of the vaccine through preclinical trials. The vaccine is estimated to take several years before it will be available to the public. (Click here for more - Japanese language